Tag - medicine

 
 

MEDICINE

As the weather gets colder, we are seeing an uptick in cases of influenza as well as COVID-19.
LIFE / Language / BILINGUAL
Nov 13, 2024
The Japanese you need to get vaccinated before winter comes
With strains of both COVID-19 and the flu circulating, learn the words that will help you navigate a visit to the clinic.
For patients using donanemab, it will cost them about ¥3.08 million per year. But national insurance coverage will have the government shoulder most of the cost.
JAPAN / Science & Health
Nov 13, 2024
Japan OKs insurance coverage of Alzheimer's drug donanemab
Donanemab became the second Alzheimer's drug that targets causative deposited plaque in the brain to win the coverage after lecanemab.
National Cancer Center Hospital building in Tokyo's Chuo Ward
JAPAN / Science & Health
Nov 9, 2024
Right-sided colon gets rid of cancer, Japanese researchers find
It has been known that colorectal cancer often occurs in the left-sided colorectum while the small intestine and the right colon are almost cancer-free.
The anterior cruciate ligament can be damaged when people play sports such as soccer and basketball, and does not heal on its own, requiring reconstructive surgery.
JAPAN / Science & Health
Nov 7, 2024
Clinical trial to use cow tendons for ligament reconstruction
The number of patients who undergo anterior cruciate ligament surgery in Japan is about 19,000 annually, including many professional soccer players and sumo wrestlers.
A pharmacist displays boxes of Ozempic in Provo, Utah.
BUSINESS
Nov 6, 2024
Obesity drug maker Novo Nordisk posts strong profit
Europe's most valuable company and the main driver of the Danish economy said it expected its 2024 full-year sales to be up by 23% to 27% from a year earlier.
The National Cancer Center Hospital in Tokyo's Chuo Ward. A study by researchers at the hospital aims to determine whether restoring a healthy intestinal environment can enhance the effectiveness of immunotherapy drugs used in cancer treatment.
JAPAN / Science & Health
Nov 6, 2024
Japan explores intestinal flora transplants for cancer treatment
A study aims to determine whether restoring a healthy intestinal environment can make drugs used in the treatment of esophageal and stomach cancers more effective.
Since October, patients have been asked to pay more for brand-name drugs prescribed by medical institutions if the patents have expired.
JAPAN
Nov 6, 2024
Japan raises out-of-pocket costs for off-patent drugs
With the increases, the government aims to reduce health care costs by encouraging greater use of generic drugs.
The winners of the Nobel Prize in Chemistry are announced in Stockholm, Sweden, on Oct. 9. They are, as seen on the display screen, David Baker (left), of the University of Washington; Demis Hassabis (center) and John M. Jumper (right), both from Google DeepMind, U.K.
COMMENTARY / World
Oct 15, 2024
Google's DeepMind Nobel Prize showcases AI’s medical potential
Google’s AlphaFold tool is already widely used by pharmaceutical researchers searching for groundbreaking new medicines.
Hiroyuki Okuzawa, chief operating officer of Daiichi Sankyo, during an interview in Tokyo on Friday
BUSINESS / Companies
Oct 11, 2024
Daiichi Sankyo eyes newer cancer drugs to stave off rivals
The Japanese drugmaker has emerged as a leader in ADC, a type of cancer therapy that targets cancerous cells while sparing the healthy ones.
Adapting to new information when faced with public health crises like COVID-19 is crucial, as oversimplified public health messaging can erode trust in science. 
COMMENTARY / World
Oct 10, 2024
The best answer science may have right now is ‘I don't know’
Acknowledging uncertainty and adapting to new information is crucial, as oversimplified public health messaging can erode trust in science.
A researcher holds a plate of nematodes in a lab at Massachusetts General Hospital in Boston on Monday. American scientists Victor Ambros and Gary Ruvkun won the Nobel Prize in Medicine the same day for their discovery of microRNA and its role in how genes are regulated.
COMMENTARY / World
Oct 9, 2024
Nobel Prize for medicine recognizes microRNA — and curiosity
Although microRNA's key role in regulating gene expression hasn't yet resulted in groundbreaking treatments, it may still significantly impact our health in the future.
A researcher works in the Ruvkun Lab in the Richard B. Simches Research Center at Massachusetts General Hospital in Boston, Massachusetts, on Monday. U.S. scientists Victor Ambros and Gary Ruvkun won the Nobel Prize in Medicine on Monday for their discovery of microRNA and its role in how genes are regulated.
WORLD
Oct 8, 2024
What is microRNA? Nobel-winning discovery explained
Several treatments and tests are under development using microRNAs against cancer, heart disease, viruses and other illnesses.
Nobel Committee Secretary-General Thomas Perlmann speaks to the media in front of a picture of this year's laureates Victor Ambros and Gary Ruvkum during the announcement of the winners of the 2024 Nobel Prize in Physiology or Medicine at the Karolinska Institute in Stockholm on Monday.
WORLD / Science & Health
Oct 7, 2024
U.S. pair wins Nobel in medicine for discovery of microRNA
Victor Ambros and Gary Ruvkun discovered the new class of tiny RNA molecules that play a crucial role in gene regulation.
A man receives a COVID-19 vaccine in Tokyo on Oct. 1. Experts say fears over the newly approved replicon vaccine are unwarranted.
JAPAN / Science & Health
Oct 7, 2024
Experts move to allay replicon COVID shot fears in Japan amid backlash
The health ministry and experts say concerns around "shedding" are unwarranted.
Children walk home from school in Ishikawa Prefecture on Sept. 26. Cases of hand, foot and mouth disease peaked a second time this year in the second week of September.
JAPAN / Science & Health
Oct 4, 2024
Hand, foot and mouth disease rebounds in Japan
The latest data — for the week of Sept. 16 to 22 — showed cases averaging roughly six times the number from the same week last year.
Community leaders discuss the role of pre-exposure prophylaxis (PrEP) in ending the HIV/AIDS threat to public health by 2030 at a seminar hosted by Gilead Sciences in Tokyo on Sept. 25.
JAPAN / Science & Health
Oct 1, 2024
HIV prevention drug remains out of reach for many in Japan despite approval
The drug's high cost together with insufficient knowledge and awareness are hindering efforts to broaden access to it, experts and community leaders say.
A woman receives a COVID-19 vaccine shot in Tokyo on Tuesday as this year's routine vaccination program for people age 65 or older began.
JAPAN / Science & Health
Oct 1, 2024
Routine COVID-19 vaccinations begin for elderly in Japan
The program mainly targets people age 65 or older. It began on Tuesday and will run until March 31 next year.
Takashi Kobayashi, a professor at Kyoto University Hospital's urology department, speaks at a news conference in Kyoto on Monday.
JAPAN / Science & Health
Oct 1, 2024
Kidney transplant between same-sex couple conducted in Kyoto
This is the first time that a living organ transplant between same-sex partners has been disclosed in Japan.
A 13-year-old junior high school student receives a vaccine for the human papillomavirus at a hospital in Tokyo in 2022.
JAPAN / Science & Health
Sep 27, 2024
Deadline approaches for free HPV vaccine 'catch-up' campaign
The government's free vaccination program requires the first dose to be administered by the end of September to complete the three-dose series before the campaign ends.
A total of 509 patients in Japan had to give up on organ transplant operations last year because hospitals were unable to carry out such procedures, according to a health ministry survey.
JAPAN / Science & Health
Sep 25, 2024
Hospital shortcomings forced 509 patients to abandon organ transplants
A lack of hospital staff and insufficient space in intensive care units needed for such operations were among the reasons.

Longform

Tetsuzo Shiraishi, speaking at The Center of the Tokyo Raids and War Damage, uses a thermos to explain how he experienced the U.S. firebombing of March 1945, when he was just 7 years old.
From ashes to high-rises: A survivor’s account of Tokyo’s postwar past